glp-1 and mash Reversing fibrosis in metabolic dysfunction–associated steatohepatitis—beyond telling patients to lose weight Novo Nordisk leads MASH therapeutic

Dfendez-vous

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study

C.ChinL

When compared with placebo, liraglutide resulted in a 4.7% increase in weight loss, semaglutide in 11.4%, tirzepatide in 12.4%, orlistat in 3.1%, naltrexone/bupropion in 4.1%, and phentermine/topiramate in 8.0%

The needle goes in at a 90-degree angle, deep into the muscle

This boost in GH levels can yield a range of potential benefits, including improved muscle growth, reduced body fat, enhanced skin elasticity, increased energy, and better sleep quality